These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 569582)

  • 1. Left ventricular function in patients with hypertrophic nonobstructive cardiomyopathy.
    Hess OM; Goebel NH; Luescher H; Schneider J; Angehrn W; Krayenbuehl HP
    Eur J Cardiol; 1979 Feb; 9(2):129-43. PubMed ID: 569582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular ejection dynamics in apical hypertrophy, a form of hypertrophic nonobstructive cardiomyopathy].
    Stierle U; Sheikhzadeh A; Diederich KW; Langbehn AF; Fröschlin R
    Herz; 1985 Apr; 10(2):72-83. PubMed ID: 3157632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serial changes in left ventricular configuration and function in hypertrophic cardiomyopathy].
    Horita Y; Genda A; Shimizu Y; Sugihara N; Suematsu T; Kita Y; Takeda R
    J Cardiol; 1988 Sep; 18(3):651-64. PubMed ID: 3249282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiographic assessment of left ventricular hypertrophy in patients with obstructive or nonobstructive hypertrophic cardiomyopathy.
    Maron BJ
    Eur Heart J; 1983 Nov; 4 Suppl F():73-91. PubMed ID: 6686547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiographic assessment of left ventricular wall motion in hypertrophic cardiomyopathy.
    Gullace G; Knippel M; Ravizza P; Savoia MT
    G Ital Cardiol; 1982; 12(8):581-9. PubMed ID: 6892016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of extent and distribution of left ventricular hypertrophy on clinical aspects and hemodynamics of patients with hypertrophic obstructive cardiomyopathy].
    Schwartzkopff B; Schwammenthal E; Lösse B; Steeg M; Strauer BE
    Z Kardiol; 1992 Jan; 81(1):15-24. PubMed ID: 1570724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Right ventricular obstruction in various types of hypertrophic cardiomyopathy.
    Stierle U; Sheikhzadeh A; Shakibi JG; Langbehn AF; Diederich KW
    Jpn Heart J; 1987 Jan; 28(1):115-25. PubMed ID: 3599397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apical hypertrophic cardiomyopathy: evaluation by noninvasive and invasive techniques in 23 patients.
    Keren G; Belhassen B; Sherez J; Miller HI; Megidish R; Berenfeld D; Laniado S
    Circulation; 1985 Jan; 71(1):45-56. PubMed ID: 4038370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic anterior motion of the mitral valve with and without asymmetric septal hypertrophy. Role of left ventricular posterior wall motion.
    Udoshi M; Shah A; Fisher VJ; Dolgin M
    Cardiology; 1980; 66(3):147-62. PubMed ID: 6447540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of asymmetrical apical hypertrophy which is a form of hypertrophic nonobstructive cardiomyopathy with giant negative T-waves.
    Sheikhzadeh A; Ghabussi P
    Jpn Heart J; 1982 Sep; 23(5):843-9. PubMed ID: 6217360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertrophic obstructive cardiomyopathy: surgical treatment and results].
    Schulte HD; Lösse B
    Herz; 1985 Apr; 10(2):102-11. PubMed ID: 4039290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Coronary circulation in asymmetrical hypertrophy of the interventricular septum. On a new pathogenic hypothesis].
    Sánchez G; Orea A; Trevethan S; Martínez Ríos MA
    Arch Inst Cardiol Mex; 1984; 54(3):235-44. PubMed ID: 6540552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy.
    Sasson Z; Rakowski H; Wigle ED
    Cardiol Clin; 1988 May; 6(2):233-88. PubMed ID: 3066484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of obstructive hypertrophic cardiomyopathy from nonobstructive hypertrophic cardiomyopathy.
    Horimoto M; Yokota K; Inoue H; Takenaka T; Doi H; Ohno T; Sekiguchi M
    Am J Cardiol; 1998 Aug; 82(3):403-5. PubMed ID: 9708680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of systolic anterior motion and left ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy].
    Hasegawa I; Sakamoto T; Hada Y; Amano K; Yamaguchi T; Takenaka K; Takahashi H; Takikawa R; Takahashi T; Sugimoto T
    J Cardiogr; 1985 Sep; 15(3):655-67. PubMed ID: 3837060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Echocardiographic evaluation of cardiac involvement in patients with chronic alcoholism].
    Houda N; Mori T; Takeuchi M; Yamamoto N; Morita N; Sugawa M; Nakano T; Takezawa H
    J Cardiogr; 1983 Sep; 13(3):551-70. PubMed ID: 6235296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Possibilities of echocardiographic evaluation of hemodynamic disorders in hypertrophic cardiomyopathy].
    Tendera M; Wodniecki J; Polonski L; Szczurek K; Kardaszewicz P; Wilczek K; Kozielska E; Kuśnierz B; Wycisk A; Wantrych M
    Kardiol Pol; 1989; 32 Suppl 1():16-22. PubMed ID: 2638428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Echocardiographic study of hypertrophic cardiomyopathy localized in the free wall of the left ventricle].
    Alcini E; Monticelli M; Pitasso L; Anastasi R
    G Ital Cardiol; 1983; 13(1):51-7. PubMed ID: 6683690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrocardiographic and angiographic follow-up of patients with hypertrophic cardiomyopathy].
    Horita Y; Genda A; Shimizu M; Mizuno S; Namura M; Igarashi Y; Sugihara N; Suematsu T; Kita Y; Takeda R
    J Cardiol; 1987 Jun; 17(2):259-72. PubMed ID: 3448167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.